Barcelona, Spain

Mari Carmen Lara Castillo


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mari Carmen Lara Castillo

Introduction

Mari Carmen Lara Castillo is a prominent inventor based in Barcelona, Spain. She has made significant strides in the field of medical research, particularly in cancer treatment. With a total of 2 patents to her name, her work focuses on innovative therapies that aim to improve patient outcomes.

Latest Patents

One of her latest patents involves a combination therapy for treating cancer. This invention relates to a combination comprising an antineoplastic agent, such as an antimetabolite antineoplastic agent, and a type 1 serotonin receptor (HTR1) modulator, specifically a HTR1 antagonist. Additionally, the invention includes a pharmaceutical composition that combines this innovative therapy with a pharmaceutically acceptable excipient. The application of this combination and pharmaceutical composition is particularly aimed at the prevention and/or treatment of hematological malignancies.

Career Highlights

Throughout her career, Mari Carmen has worked with notable organizations, including Leukos Biotech and the Fundació Institut De Recerca Contra La Leucèmia Josep Carreras. Her contributions to these institutions have been instrumental in advancing research and development in the field of oncology.

Collaborations

Mari Carmen has collaborated with esteemed colleagues such as Ruth Muñoz Risueño and Amaia Etxabe Alberdi. These partnerships have fostered a collaborative environment that enhances the innovation process in her research endeavors.

Conclusion

Mari Carmen Lara Castillo's work exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations reflect her commitment to advancing cancer treatment and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…